This project continues to focus on the use of immunologic techniques to monitor human exposure to aflatoxin B1 (AFB1) which, in conjunction with hepatitis B virus (HBV) infection, is believed to be a causative factor in elevated levels of hepatocellular carcinoma (HCC) in Taiwan. Monoclonal antibodies developed against the DNA and protein adducts of AFB1 will be used to monitor AFB1 exposure. Genetic differences in metabolic capacity, which may be responsible for the interindividual differences observed in adduct levels, will be investigated. Cytochrome P450 1A1, 1A2 and 3A4 and glutathione S transferase mu (GSTM1) levels will be determined in tumor and nontumor tissue of HCC patients and controls by Western blot analysis. GSTM1 will also be genotyped by PCR. This data will be correlated with AFB1-DNA adduct levels determined by competitive ELISA of isolated DNA and quantitative immunohistochemical analysis of tissue sections. Specific p53 mutations will be analyzed in the liver tumors by both immunohistochemical methods and single strand conformation polymorphism followed by sequencing. Two case-control studies will determine the potential role of AFB1- albumin adducts as predictors of risk for HCC induction. The first will use banked serum samples from a community based nested case-control study in 6 townships in Taiwan. AFB1-albumin adducts will be determined by competitive ELISA and the inter-relationship between AFB1 exposure, family history, HBV carrier status and risk for developing HCC will be investigated. The second will use samples being collected in an ongoing cancer screening program throughout Taiwan which has to date, banked samples from 20,000 individuals. Since white blood cells as well as serum are being stored, GSTM1 genotype will also be determined. The relationship between AFB1-albumin adducts and GSTM1 genotype will be investigated as well as their relationship to HCC induction. This proposal will provide important information on the role of AFB1 in HCC induction in Taiwan and an understanding of some genetic factors influencing individual cancer risk.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
2R01ES005116-04A1
Application #
3253352
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1990-01-01
Project End
1996-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Public Health
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Chu, Yu-Ju; Yang, Hwai-I; Wu, Hui-Chen et al. (2018) Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. Eur J Cancer 94:37-46
Chu, Yu-Ju; Yang, Hwai-I; Wu, Hui-Chen et al. (2017) Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. Int J Cancer 141:711-720
Yeh, Chih-Ching; Goyal, Abhishek; Shen, Jing et al. (2017) Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma. Ann Surg Oncol 24:3788-3795
Zeng, Hui; Wu, Hui-Chen; Wang, Qiao et al. (2017) Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort. Anticancer Res 37:637-644
Wu, Hui-Chen; Yang, Hwai-I; Wang, Qiao et al. (2017) Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population. Carcinogenesis 38:1021-1028
Shen, Jing; Wang, Qiao; Gurvich, Irina et al. (2016) Evaluating normalization approaches for the better identification of aberrant microRNAs associated with hepatocellular carcinoma. Hepatoma Res 2:305-315
Wu, Hui-Chen; Shen, Jing; Yang, Hwai-I et al. (2016) Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan. World J Hepatol 8:301-6
Shen, Jing; Siegel, Abby B; Remotti, Helen et al. (2016) Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies. Hepatoma Res 2:151-162
Ruan, Peifeng; Shen, Jing; Santella, Regina M et al. (2016) NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals. Nucleic Acids Res 44:e134
Shen, Jing; Yeh, Chih-Ching; Wang, Qiao et al. (2016) Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation. Anticancer Res 36:5307-5314

Showing the most recent 10 out of 48 publications